查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869805

口腔黏膜炎市場規模、佔有率和趨勢分析報告：按療法、分銷管道、地區和細分市場預測（2025-2033 年）

Oral Mucositis Market Size, Share & Trends Analysis Report By Treatment (Growth Factor, Barrier, Topical Analgesics, Cryotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

口腔黏膜炎市場摘要

2024年全球口腔黏膜炎市場規模估計為15億美元，預計2033年將達到28.5億美元。

預計從 2025 年到 2033 年，口腔黏膜炎市場將以 7.35% 的複合年成長率成長。口腔粘膜炎 (OM) 日益嚴重的臨床負擔是推動口腔粘膜炎市場成長的主要因素之一。

口腔粘膜炎是化療和放療的常見併發症，放射線治療進一步推動了口腔粘膜炎市場的發展。此外，人們對輔助治療方案的日益關注以及提高癌症患者生活品質的需求也促進了市場需求。持續進行口腔黏膜炎預防和治療性介入的研究與發展也是推動市場成長的重要因素。

癌症病例的日益增多推動了口腔黏膜炎治療產業的成長。世界衛生組織（WHO）預測，2050年，全球新增癌症病例將超過3,500萬例，比2022年估計的2,000萬例增加77%。這一數字反映了人口老化和人口成長的雙重趨勢。人口成長導致接受化療和放射線治療的患者人數增加，而口腔粘膜炎常常是這些治療的副作用。此外，癌症治療方法的進步提高了存活率，擴大了需要輔助治療的患者群體。這導致對有效口腔粘膜炎治療方法的需求不斷成長，市場持續擴大。

常規的臨床評估和管理指南的進步為口腔粘膜炎的治療提供了支持。 2024年6月，多國癌症支持治療協會（MASCC）和國際口腔腫瘤學會（ISOO）發布了更新的指南，建議使用世界衛生組織（WHO）口腔毒性評分量表評估臨床試驗中的口腔黏膜炎。這項國際標準支持在各種評估環境中實現標準化，包括放射治療和造血幹細胞移植（HSCT）。這些指南有望改善病患監測，促進新療法的研發，並有助於有效口腔粘膜炎干預措施的廣泛應用，從而推動市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 口腔黏膜炎市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析

第4章 口腔黏膜炎市場：治療業務分析

  • 2024 年和 2033 年治療市場佔有率
  • 治療細分儀表板
  • 按療法分類的市場規模、預測和趨勢分析，2021-2033年
  • 生長因子/上皮保護劑
  • 阻隔/塗層凝膠和沖洗液
  • 局部止痛藥
  • 冷凍療法
  • 低功率雷射/光生物調節療法（LLLT）
  • 抗菌劑

第5章 口腔黏膜炎市場：通路業務分析

  • 2024 年及 2033 年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 按分銷管道分類的市場規模、預測和趨勢分析，2021-2033年
  • 醫院藥房
  • 零售藥房
  • 其他

第6章 口腔黏膜炎市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析（2021-2033）：
  • 北美洲
    • 按國家/地區分類，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介
    • Amgen Inc.
    • EpicentRx, Inc.
    • Pfizer Inc.
    • Soleva Pharma, LLC.
    • Basic Pharma Life Science Pvt Ltd.
    • CANbridge Pharmaceuticals Inc.
    • Enzychem Lifesciences Corporation
    • Galera Therapeutics, Inc.
    • Helsinn Healthcare SA.
    • Monopar Therapeutics, Inc.
    • Swedish Orphan Biovitrum AB
    • Innovation Pharmaceuticals Inc.
Product Code: GVR-4-68040-781-0

Oral Mucositis Market Summary

The global oral mucositis market size was estimated at USD 1.50 billion in 2024 and is projected to reach USD 2.85 billion by 2033, growing at a CAGR of 7.35% from 2025 to 2033. The rising clinical burden of Oral Mucositis (OM) is one of the major factors driving the market growth for oral mucositis.

OM is a frequent complication of chemotherapy and radiotherapy, and increasing cancer treatment further impacts the OM market positively. In addition, the growing awareness of supportive care options and the need to improve patients' quality of life during cancer treatment are boosting market demand. Continuous research and development in preventive and therapeutic interventions for oral mucositis is also driving the market's growth.

Increasing cases of cancer day by day are driving growth in the oral mucositis industry. The World Health Organization (WHO) projects over 35 million new cancer cases by 2050, a 77% increase from an estimated 20 million cases in 2022, reflecting both population aging and growth. This increase leads to a larger number of patients undergoing chemotherapy and radiotherapy, which frequently results in oral mucositis as a side effect. Furthermore, improvements in cancer therapies have enhanced survival rates, expanding the population requiring supportive care. Demand for effective oral mucositis treatments is increasing, and the market is growing.

Advancements in regular clinical assessment and management guidelines support oral mucositis treatment. In June 2024, the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO) released updated guidance recommending the WHO Oral Toxicity Scale for OM assessment in clinical trials. This global standard assists in standardizing assessment within various evaluation environments, such as radiotherapy and hematopoietic stem cell transplantation (HSCT). These guidelines will help ensure better patient monitoring, accelerate the development of new treatments, and promote effective OM interventions more widely, which is expected to drive market growth.

Global Oral Mucositis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oral mucositis market report based on treatment, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2021 - 2033)
  • Growth factor / Epithelial Protective Agents
  • Barrier/ Coating Gels and Rinses
  • Topical analgesics
  • Cryotherapy
  • Low-level Laser/ Photobiomodulation therapy (LLLT)
  • Antimicrobials
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Oral Mucositis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Oral Mucositis Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2033
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
  • 4.4. Growth Factor /Epithelial Protective Agents
    • 4.4.1. Growth Factor /Epithelial Protective Agents Market, 2021 - 2033 (USD Million)
  • 4.5. Barrier/Coating Gels and Rinses
    • 4.5.1. Barrier/Coating Gels and Rinses Market, 2021 - 2033 (USD Million)
  • 4.6. Topical Analgesics
    • 4.6.1. Topical Analgesics Market, 2021 - 2033 (USD Million)
  • 4.7. Cryotherapy
    • 4.7.1. Cryotherapy Market, 2021 - 2033 (USD Million)
  • 4.8. Low-level Laser/Photobiomodulation Therapy (LLLT)
    • 4.8.1. Low-level Laser/Photobiomodulation Therapy Market, 2021 - 2033 (USD Million)
  • 4.9. Antimicrobials
    • 4.9.1. Antimicrobials Market, 2021 - 2033 (USD Million)

Chapter 5. Oral Mucositis Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2033
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
  • 5.6. Other
    • 5.6.1. Other Market, 2021 - 2033 (USD Million)

Chapter 6. Oral Mucositis Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Oral Mucositis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Type Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Type Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Type Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Type Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Type Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Type Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Type Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Type Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Type Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Type Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Type Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Type Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Type Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Oral MucositisMarket Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Type Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Type Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Type Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Type Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Type Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Type Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Type Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Type Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Type Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Type Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Oral Mucositis Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Amgen Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. EpicentRx, Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Pfizer Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Soleva Pharma, LLC.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Basic Pharma Life Science Pvt Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. CANbridge Pharmaceuticals Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Enzychem Lifesciences Corporation
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Galera Therapeutics, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Helsinn Healthcare SA.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Monopar Therapeutics, Inc.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Swedish Orphan Biovitrum AB
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Innovation Pharmaceuticals Inc.
      • 7.5.12.1. Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global oral mucositis market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 5. Global oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6. North America oral mucositis market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 8. North America oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9. U.S. oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 10. U.S. oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11. Canada oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 12. Canada oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13. Mexico oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 14. Mexico oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15. Europe oral mucositis market, by country, 2021 - 2033 (USD Million)
  • Table 16. Europe oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 17. Europe oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18. UK oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 19. UK oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20. Germany oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 21. Germany oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22. France oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 23. France oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24. Italy oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 25. Italy oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26. Spain oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 27. Spain oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28. Norway oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 29. Norway oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30. Denmark oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 31. Denmark oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32. Sweden oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 33. Sweden oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific oral mucositis market, by country, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 36. Asia Pacific oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37. Japan oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 38. Japan oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39. China oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 40. China oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41. India oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 42. India oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43. Australia oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 44. Australia oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45. South Korea oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 46. South Korea oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47. Thailand oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 48. Thailand oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 49. Latin America oral mucositis market, by country, 2021 - 2033 (USD Million)
  • Table 50. Latin America oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 51. Latin America oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52. Brazil oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 53. Brazil oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54. Argentina oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 55. Argentina oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa oral mucositis market, by country, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 58. Middle East & Africa oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59. South Africa oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 60. South Africa oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 62. Saudi Arabia oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63. UAE oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 64. UAE oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65. Kuwait oral mucositis market, by treatment, 2021 - 2033 (USD Million)
  • Table 66. Kuwait oral mucositis market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Oral mucositis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Oral mucositis market dynamics
  • Fig. 12 Oral mucositis market: Porter's five forces analysis
  • Fig. 13 Oral mucositis market: PESTLE analysis
  • Fig. 14 Treatment market, 2021 - 2033 (USD Million)
  • Fig. 15 Growth factor /epithelial protective agents market, 2021 - 2033 (USD Million)
  • Fig. 16 Barrier/coating gels and rinses market, 2021 - 2033 (USD Million)
  • Fig. 17 Topical analgesics market, 2021 - 2033 (USD Million)
  • Fig. 18 Cryotherapy market, 2021 - 2033 (USD Million)
  • Fig. 19 Low-level laser/photobiomodulation therapy (LLLT) market, 2021 - 2033 (USD Million)
  • Fig. 20 Antimicrobials market, 2021 - 2033 (USD Million)
  • Fig. 21 Distribution channel market, 2021 - 2033 (USD Million)
  • Fig. 22 Hospital pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 23 Retail pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 24 Other market, 2021 - 2033 (USD Million)
  • Fig. 25 Oral mucositis market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 34 Europe oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 45 Norway country dynamics
  • Fig. 46 Norway oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden country dynamics
  • Fig. 48 Sweden oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 52 Japan country dynamics
  • Fig. 53 Japan oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 54 China country dynamics
  • Fig. 55 China oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 56 India country dynamics
  • Fig. 57 India oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 58 Australia country dynamics
  • Fig. 59 Australia oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil country dynamics
  • Fig. 66 Brazil oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina country dynamics
  • Fig. 68 Argentina oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 69 MEA oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 70 South Africa country dynamics
  • Fig. 71 South Africa oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia country dynamics
  • Fig. 73 Saudi Arabia oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 74 UAE country dynamics
  • Fig. 75 UAE oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 76 Kuwait country dynamics
  • Fig. 77 Kuwait oral mucositis market, 2021 - 2033 (USD Million)
  • Fig. 78 Company categorization
  • Fig. 79 Company market position analysis
  • Fig. 80 Strategic framework